Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients.
Mingrone G, Astarita A, Airale L, Maffei I, Cesareo M, Crea T, Bruno G, Leone D, Avenatti E, Catarinella C, Salvini M, Cetani G, Gay F, Bringhen S, Veglio F, Vallelonga F, Milan A. Mingrone G, et al. Among authors: catarinella c. Front Cardiovasc Med. 2021 Apr 21;8:645678. doi: 10.3389/fcvm.2021.645678. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33969010 Free PMC article.
Prognostic role of the ascending aorta dilatation in patients with arterial hypertension.
Leone D, Airale L, Bernardi S, Mingrone G, Astarita A, Cesareo M, Sabia L, Avenatti E, Tosello F, Bruno G, Catarinella C, Venturelli V, Giordana C, Veglio F, Vallelonga F, Milan A. Leone D, et al. Among authors: catarinella c. J Hypertens. 2021 Jun 1;39(6):1163-1169. doi: 10.1097/HJH.0000000000002752. J Hypertens. 2021. PMID: 33710167
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Astarita A, Mingrone G, Airale L, Vallelonga F, Covella M, Catarinella C, Cesareo M, Bruno G, Leone D, Giordana C, Cetani G, Salvini M, Gay F, Bringhen S, Rabbia F, Veglio F, Milan A. Astarita A, et al. Among authors: catarinella c. Cancers (Basel). 2021 Apr 1;13(7):1631. doi: 10.3390/cancers13071631. Cancers (Basel). 2021. PMID: 33915804 Free PMC article.
Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience.
Mingrone G, Astarita A, Colomba A, Catarinella C, Cesareo M, Airale L, Paladino A, Leone D, Vallelonga F, Bringhen S, Gay F, Veglio F, Milan A. Mingrone G, et al. Among authors: catarinella c. Cancers (Basel). 2023 Feb 10;15(4):1149. doi: 10.3390/cancers15041149. Cancers (Basel). 2023. PMID: 36831492 Free PMC article.
Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study.
Astarita A, Mingrone G, Airale L, Cesareo M, Colomba A, Catarinella C, Leone D, Gay F, Bringhen S, Veglio F, Milan A, Vallelonga F. Astarita A, et al. Among authors: catarinella c. Cancers (Basel). 2023 Feb 2;15(3):955. doi: 10.3390/cancers15030955. Cancers (Basel). 2023. PMID: 36765915 Free PMC article.